The Effect of Progressive Muscle Relaxation and Deep Breathing Exercises Applied to Palliative Care Cancer Patients on Dyspnea, Fatigue, and Self-Care Behaviors
NCT07619209
Summary
The purpose of this study is to evaluate the effects of Progressive Muscle Relaxation (PMR) exercises and deep breathing exercises on dyspnea, fatigue, and self-care behaviors among cancer patients receiving palliative care. Advanced-stage cancer patients frequently experience debilitating symptoms such as shortness of breath (dyspnea) and severe fatigue, which significantly impair their functional capacity and daily self-care activities. Participants in this study will be assigned to either a progressive muscle relaxation intervention group or a structured deep breathing exercise group. The study aims to determine whether these non-pharmacological relaxation techniques can effectively reduce the severity of dyspnea and fatigue, thereby improving the patients' overall self-care behaviors and physical comfort in a palliative care setting.
Eligibility
Inclusion Criteria: * Being 18 years of age or older Being literate (able to read and write) Having no significant hearing or visual impairment that prevents communication or cooperation Receiving treatment in the palliative care unit Having a confirmed medical diagnosis of cancer Having a Glasgow Coma Scale (GCS) score of 10 or higher Being able to communicate via telephone and SMS for post-discharge follow-up Having a Common Terminology Criteria for Adverse Events (CTCAE) Dyspnea Classification of Grade 3 or below Having an ECOG Performance Status Scale score of 3 or below Having a Hemoglobin (Hb) value of 8 gm/dL or higher Volunteering to participate in the study and providing informed consent Exclusion Criteria: * Currently practicing or having recently practiced Progressive Muscle Relaxation (PMR) or deep breathing exercises actively Having a primary respiratory system disease diagnosis (such as COPD, asthma, or pneumonia) Having a medical diagnosis of dementia, agitation, or delirium Receiving Continuous Positive Airway Pressure (CPAP) or Bilevel Positive Airway Pressure (BiPAP) support Being on active antipsychotic or sedative medical treatment Having a Common Terminology Criteria for Adverse Events (CTCAE) Dyspnea Classification of Grade 4 or higher
Conditions5
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07619209